Drug Enforcement Administration, Hearing Before the Subcommittee on Crime, Terrorism, Homeland Security and Investigations of the Committee on the Judiciary, U.S. House of Representatives, One Hundred Thirteenth Congress, Second Session, September 18, 2014 [open pdf - 659KB]
This is the September 18, 2014 hearing on "The Drug Enforcement Administration," held before the U.S. House Committee on the Judiciary. From the opening statement of Bob Goodlatte: "Just last week, this Committee reported two bills that directly affect DEA [Drug Enforcement Administration] operations. H.R. 4299 addresses concerns that I and other members have with the increasing length of time DEA has expended in recent years to schedule new controlled substances, thus delaying patient access to new therapies. Reducing these scheduling timeframes is important. But it should not be achieved by eliminating DEA's critical role in the scheduling process. The substitute amendment I offered in markup codified a reasonable, shorter scheduling timeframe while preserving its vital role in the scheduling process. H.R. 4771 adds 25 new substances to the list of anabolic steroids in the Controlled Substances Act. In cooperation with our Democratic colleagues, the Judiciary Committee unanimously approved a substitute amendment to remove an unnecessary -- and largely redundant -- criminal penalty and streamline the civil penalties for the illicit manufacture, distribution, and dispensation of these substances. […] The selective enforcement of federal law and lack of respect for the constitutional separation of powers has become the hallmark of the Obama Administration. It is a source of profound concern for me and the Members of this Committee. Again, it is Congress's responsibility to make policy decisions about whether to address mandatory minimums and other hot-button items. It is the Administration's responsibility to enforce the laws." Statements, letters, and materials submitted for the record include those of the following: Michele M. Leonhart.
House Hearing 113-109; H. Hrg. 113-109; Serial No. 113-109
Government Printing Office [GPO]: http://www.gpo.gov/